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Myelin allows fast and reliable conduction of nerve pulses
Myelin is a fatty substance that ensheathes the axon of some nerve cells, forming an
electrically insulating layer. It is considered a defining characteristic of jawed vertebrates
and is essential for the proper functioning of the nervous system of these latter. Myelin
is made by different cell types, and varies in chemical composition and configuration, but
performs the same insulating function. Myelinated axons look like strings of sausages
under a microscope, and because of their white appearance they are integral components
of the “white matter” of the brain. The myelin sausages ensue from wrapping of axons
by myelin in multiple, concentric layers and are separated from each others by small
unmyelinated axonal segments known as nodes of Ranvier. Typically the length of a node
is very small (0.1%) compared to the length of the myelinated segment. Single myelinated
fibers range in diameter from 0.2 to 20 µm on average, while unmyelinated fibers range
between 0.1 and 1 µm [1]. Peripheral axons are myelinated only if their diameter is larger
than about 1 µm, and the axonal caliber maintains a rather constant ratio to the myelin
sheath thickness [2]. A normal myelin ensheathing of a mature peripheral nerve is usually
100 times as long as the diameter of the corresponding axon [3].
Like insulating tape around an electrical wire, myelin helps to insulate the axons from
electrically charged atoms and molecules that are found in the fluid surrounding the entire
nervous system. Yet, the main purpose of myelin likely is to increase the speed at which
neural electrical impulses propagate along the nerve fiber. Along unmyelinated fibers,
impulses move continuously as waves, but, in myelinated fibers, they “hop” or propagate
by a process known as saltatory conduction. Myelin in fact decreases capacitance and
increases electrical resistance across the cell membrane (the axolemma) thereby helping
to prevent the electric current from leaving the axon. This is achieved by a heterogeneous
distribution of voltage-gated sodium channels along myelinated fibers, whose density is
low (∼25 channels/µm2) along myelinated internodes (i.e. the myelin “sausages”) but
high at the nodes of Ranvier (between 2000 and 12000 channels/µm2) [4]. In this fash-
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ion, sodium leakage into the extracellular fluid (ECF) is reduced along the myelinated
internodes, thereby maintaining a strong separation of electrical charge between the in-
tracellular fluid and the ECF. This increases sodium’s ability to travel along the axon
more freely. However, although sodium diffuses along the axolemma rapidly, this process
is decremental by nature so that sodium cannot trigger the opening of the voltage-gated
sodium channels as it becomes weaker. The nodes of Ranvier, on the contrary, contain
large amounts of voltage-gated sodium channels and are easily excited as they are exposed
to the ECF allowing enough sodium into the axon to regenerate the action potential [5].
An action potential is thus restored to the original depolarization at onset at the axon
hillock each time it reaches a node of Ranvier and travels fast along the myelinated axon,
hopping from one node of Ranvier to the following one, with a propagation speed that
can exceed 10–50 m/s in humans [6, 7].
Specialized glial cells are responsible of myelin production
Production of myelin – a process known as myelination or myelogenesis – is by spe-
cialized glial cells: oligodendrocytes myelinate the axons of the central nervous system
(CNS), whereas Schwann cells supply the myelin for the peripheral nervous system (PNS).
Oligodendrocytes and Schwann cells are small cells with relatively few processes, yet with
distinct structural differences. While oligodendrocytes can envelop from one to 30 axonal
segments (i.e. internodes) depending on axon diameter, one Schwann cell only envelops
a single segment of one peripheral axon. Moreover, Schwann cells, but not oligodendro-
cytes, are surrounded by a basal lamina that forms the demarcation to the mesenchymal
environment with the nerve [8]. Both oligodendrocytes and Schwann cells not only in-
fluence axons by enhancing signal conduction by myelin sheaths but are also responsible
of segregating voltage-sensitive ion channels into distinct axonal domains that form the
nodes of Ranvier. In addition to formation, maturation and maintenance of nodes of
Ranvier are further key functions of these cells [9].
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The periodicity of nodes of Ranvier along axons is directly and positively related to
axon caliber [10]. In the CNS, internodal lengths are relatively uniform, ranging from
50 to 500 µm depending on oligodendrocyte nature [11, 12], and nodal periodicity is
established developmentally before myelin compaction [13, 14]. As axons grow in length,
unmyelinated gaps are myelinated by late developing oligodendrocytes, and this continues
well into adulthood, which could explain the extremely short internodes observed in
oligodendrocytes of late myelinated areas such as the cortex [15]. In the PNS, on the
contrary, the internodal distance can reach 1 to 1.5 mm [16]. This means that if we
consider the human femoral nerve, whose primary axon is approximately 0.5 m, there
are approximately 300 to 500 nodes of Ranvier occurring along a primary afferent fiber
between the thigh muscle and the cell body in the dorsal root ganglion. Because each
internodal segment is formed by a single Schwann cell, then as many as 500 Schwann
cells could participate in the myelination of each peripheral sensory axon [9].
Myelinating glial cells and axons are entirely interdependent and should be regarded
as functional units rather than separate functional entities per se [15]. Neuronal signaling
molecules and electrical activity trigger the proliferation of axon-associated glial cells and
control the synthesis of myelin [17–19]. Likewise, myelin proteins are essential for axon
radial growth and protection from extracellular insults. Additionally, in the presence of
injury or pathology, axonal signals are allegedly required for survival of myelinating glial
cells, and reciprocally, demyelinated axons do not survive indefinitely when they lose
their myelin. Severed myelinated fibers may only regenerate in the PNS but not in the
CNS [9].
Myelination is fundamental for normal brain function
In humans, myelination begins as early as in the third trimester after birth, although
little myelin already exists in the brain at the time of birth – and quickly occurs during
infancy leading to a child’s fast development, including crawling and walking in the first
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year [20]. Myelination continues through adolescences up to the fifth decade of life [21].
Normal aging, on the other hand, correlates with degenerative changes in myelin, such as
shorter internodes or thinners myelin sheaths or splitting, blebbing, ballooning of these
latter [22, 23].
Magnetic resonance imaging has revealed many examples of differences in white mat-
ter structure that correlate with specific cognitive abilities such as learning to read [24],
juggling [25] or complex skills like playing the piano [26]. In this latter case, for exam-
ple, the level of white matter structure seems to increase proportionately to the number
of hours each subject practice piano, indicating that white matter changes in acquir-
ing the skill, rather than performance being pre-determined by a limitation on white
matter development. On the other hand, lack of myelination, active demyelination, loss
of myelinating glial cells or a combination thereof, associate with age-related cognitive
decline [21, 27] as well as neurological disorders like major depressive disorder [28] and
schizophrenia [29].
When a peripheral fiber is severed, the myelin sheath provides a track along which
regrowth can occur. However, the myelin layer does not ensure a perfect regeneration
of the nerve fiber. Some regenerated nerve fibers do not find the correct muscle fibers,
and some damaged motor neurons of the peripheral nervous system die without regrowth.
Damage to the myelin sheath and nerve fiber is often associated with increased functional
insufficiency [9].
In general, many diseases of the nervous system involve myelin [30]. Multiple sclero-
sis (MS) is one of the most common neurological diseases affecting the CNS. It involves
demyelination, likely due to an autoimmune attack on myelin and oligodendrocytes. Al-
though, in most cases of relapsing and remitting MS, it appears that there is initial
remyelination due to the generation of new oligodendrocytes and new myelin, at some
point in the disease this repair process fails leading to unrecoverable motor and cognitive
deficits [31]. In the PNS, autoimmune reactions to proteins P0 and PMP22 that are main
components of peripheral myelin produce instead a demyelinating peripheral neuropathy:
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the Guillain-Barre´ syndrome [32]. Mutations in myelin protein genes also cause a variety
of demyelinating diseases in both peripheral and central axons. In the CNS, one example
is the Pelizaeus-Merzbacher disease, a leukodystrophy in humans resulting from a reces-
sive mutation of the gene on the long arm of the X-chromosome (Xq21-22) that codes for
a myelin protein called proteolipid protein 1 (or PLP1) [33]. In the PNS, a duplication
of the PMP22 gene on chromosome 17 causes instead one form of Charcot-Marie-Tooth
disease, which is the most common inherited peripheral neuropathy, and is characterized
by progressive muscle weakness, greatly decreased conduction in peripheral nerves, and
cycles of demyelination and remyelination [34].
Overall, demyelination slows down, or even stops, conduction of the action potential in
an affected axon, because it allows electrical current to leak out of the axonal membrane.
Thus, demyelinating diseases have devastating effects on neuronal circuits in the brain,
spinal cord, and peripheral nervous system.
Iron balance is critical to myelination
Iron is an essential metal in biological systems where it is necessary for the consumption
of oxygen and production of adenosine trisphosphate (ATP) which is a key molecule
for intracellular energy transfer. It is also involved in cholesterol and neurotransmitter
synthesis and protein degradation. Because of the ability of iron to interact with oxygen,
it can also be a potent generator of free radicals. Thus cells have developed an elegant
system to keep iron bound to proteins during delivery to cells and storage therein [35].
Iron and glia have both distinctive regional and cellular distribution. At the regional
level, iron is most prominent in areas associated with motor functions such as basal
ganglia, substantia nigra (pars reticulata) and deep cerebellar nuclei and is also present
in high concentration in white matter [36]. At the cellular level, the cells that most
prominently need iron for normal function appear to be oligodendrocytes [37]. These
cells may acquire iron either in earlier stages of development or uptake it as H-ferritin,
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both from the blood-brain barrier (mainly, but not exclusively, by astrocyte-mediated
pathways) and from microglia. Ferritin is then used by oligodendrocytes for maturation
and myelin production [38].
Oligodendrocytes are also the most sensitive to low iron insofar as hypomyelination
is a consistent finding of decreased iron availability both in development and adults
[39]. There is also emerging evidence that iron changes in white matter tracts may
mark demyelination, which could be clinically meaningful information to guide timing of
treatment intervention [40]. A further area of active investigation is on the role of genetic
variations that impact brain iron status, and hence myelination, leading to alterations in
rates of cognitive decline with age or degree of damage with disease.
Iron balance is critical to glial function given that proinflammatory cytokines, hypoxia
and other means of damage to the brain use the ability of iron to generate oxidative stress
to promote cell death in all of glial subtypes, but the most sensitive are oligodendrocytes
followed by astrocytes and then microglia [41]. Remarkably, the ability of iron chelation to
protect oligodendrocytes not only from direct exposure to proinflammatory cytokines but
also from the toxic effects of activated microglia, suggest that attempts to use this method
to treat hypoxic or ischemic injury and demyelinating diseases are well founded [42, 43].
There is indeed clear evidence that iron chelation will decrease inflammatory reaction,
although the challenge remains in the delivery of the iron chelator and the timing of
delivery. The chelating compound or the mechanism of delivery must be able to traverse
the blood-brain barrier in adequate amounts. Moreover, the chelating compound has
to discern between “good” and “bad” iron not to limit energy production that may be
needed for remyelination.
Preliminary experiments in cell culture models suggest that commercially available
chelators like deferoxamine (DFOA) could be viable clinical options to limit damage of
glial cells by hypoxia, ischemia and traumatic brain injury, although more research is
needed to identify the physiological mechanisms that could regulate the chelating com-
pound both in terms of amount of iron being chelated and the distribution of the chelator
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with the brain [44]. Lowering dietary iron may be one way to limit iron available to exac-
erbate damage associated with neurological trauma, but again, iron must be reintroduced
for remyelination and return to normal function [45, 46].
Oxidative stress could be a key mechanism in demyelinating disorders. Substantial
histological evidence exist indeed for ongoing oxidative stress in demyelination by multiple
sclerosis [47]. Moreover, in support of a role of iron and oxidative stress in promotion of
demyelination is the finding that iron deposit in the white matter in multiple sclerosis
and that treatment with an iron chelator or an antioxidant can limit the amount of
demyelinaton and behavioral abnormalities that are associated with experimental allergic
encephalomyelitis [47–49].
A further area that involves oxidative stress damage is radiation used to treat brain
tumors. Oligodendrocytes are the most radiosensitive of glial cells [50] and human white
matter specimens obtained post-radiation confirm a delayed onset of demyelination which
correlates with loss of oligodendrocyte function [51]. Although there is not direct evidence
that iron could contribute to radiosensitivity of oligodendrocytes, it is worth noting that
exposing oligodendrocytes in cell cultures to radiation increases oxidative stress sixfold
in these cells [52], suggesting that such increase in oxidative stress could be prevented by
iron chelation.
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